Clinical Trials Browser

Phase 2 × Opioid-Related Disorders × Psilocybin × Clear all

NCT06001749 2025-12-16

Psilocybin in Cancer Pain Study

Phase 2 Recruiting

Agnosia, Opioid-Related Disorders